Yes, mifepristone is used to manage miscarriage, and clinical evidence shows it significantly improves outcomes when added to standard treatment. While most people associate mifepristone with elective abortion, it plays an increasingly recognized role in helping the body complete an early pregnancy loss without surgery. The American College of Obstetricians and Gynecologists (ACOG) recommends that a dose of mifepristone be considered before the standard medication whenever it is available.
How Mifepristone Helps During Miscarriage
When a miscarriage is diagnosed but the body hasn’t fully passed the pregnancy tissue on its own, there are three options: wait for it to happen naturally, use medication to help it along, or have a surgical procedure. The medication approach has traditionally relied on misoprostol alone, which triggers uterine contractions. Adding mifepristone beforehand makes that process work considerably better.
Mifepristone blocks progesterone, the hormone responsible for maintaining the uterine lining and supporting early pregnancy. By interrupting progesterone’s effects, mifepristone causes the body to release its own prostaglandins, natural compounds that soften the cervix and make the uterus more responsive to contractions. This essentially primes the body so that when misoprostol is given 24 to 48 hours later, the uterus contracts more effectively and passes the remaining tissue more completely.
Success Rates With and Without Mifepristone
A double-blind randomized controlled trial published in the European Journal of Obstetrics & Gynecology and Reproductive Biology found that adding mifepristone raised the success rate of medical miscarriage management from 82.5% to 94.3%. That 12-point jump translated to a 61% reduction in the number of patients who ultimately needed a surgical procedure to complete the process. The rate of surgical intervention dropped from 14.6% with misoprostol alone to just 5.7% with the combination. Importantly, the addition of mifepristone did not increase side effects or make the experience less acceptable to patients.
What the Process Looks Like
The protocol follows a two-step sequence. On the first day, you take a single 200 mg tablet of mifepristone by mouth. Then, 24 to 48 hours later, you use 800 micrograms of misoprostol, which can be placed vaginally or in the cheek pouch depending on the protocol your provider follows. If the first dose of misoprostol doesn’t produce a response, a repeat dose can be given, typically no earlier than 3 hours after the first and within 7 days. A follow-up appointment is usually scheduled about one to two weeks later to confirm the miscarriage is complete.
When Bleeding Starts and How Long It Lasts
A prospective study tracking bleeding patterns found that many patients begin bleeding before they even take the second medication. About 40% reported vaginal bleeding starting between the mifepristone dose and the misoprostol dose, on day one or day two. The highest proportion of patients, around 45%, had bleeding begin on day three, when misoprostol was taken. No participants in the study reported bleeding starting later than day three.
The heaviest bleeding typically lasts about 5 days, though it can range from 4 to 7 days. Lighter bleeding and spotting continue for a median of 13 days total. This timeline is useful to know because it helps set realistic expectations. The heavy phase, which often involves passing clots and tissue, is the most physically intense part. After that, the bleeding gradually tapers to something resembling a light period or spotting.
FDA Approval and Off-Label Use
The FDA approved mifepristone specifically for medical termination of pregnancy through ten weeks of gestation. It does not currently carry a separate FDA indication for miscarriage management. However, doctors routinely prescribe it off-label for this purpose, which is a standard and legal practice in medicine. ACOG’s clinical guidance explicitly recommends considering mifepristone before misoprostol for early pregnancy loss, reflecting the weight of evidence supporting its use in this context.
This distinction matters in practical terms. Depending on where you live and the policies of your pharmacy or clinic, access to mifepristone for miscarriage management may vary. Some providers may only offer misoprostol alone, not because it’s the preferred protocol, but because of supply, regulatory, or institutional constraints.
Who Should Not Take Mifepristone
Mifepristone is not appropriate for every situation. It should not be used when a pregnancy is ectopic, meaning it has implanted outside the uterus, because the medication will not resolve that type of pregnancy and the delay could be dangerous. It is also not suitable for people with certain bleeding disorders, chronic adrenal failure, or those taking long-term corticosteroids, since the drug’s mechanism of blocking progesterone can interfere with related hormonal pathways. An intrauterine device (IUD) needs to be removed before treatment. Your provider will confirm the miscarriage diagnosis with ultrasound and rule out these contraindications before prescribing the medication.
How It Compares to Other Options
For early pregnancy loss in the first trimester, you generally have three paths. Expectant management, simply waiting, works for some people but can take days to weeks with no guarantee of completion. Surgical evacuation is quick and highly effective but involves anesthesia and the small risks that come with any procedure. Medical management with mifepristone and misoprostol falls in between: it avoids surgery in the vast majority of cases while giving the process a defined timeline.
The combination approach is particularly valuable for patients who want to avoid a procedure but don’t want the uncertainty of waiting indefinitely. With a 94% success rate, most people who choose this route will complete the miscarriage without needing any further intervention. For the small percentage who do need a surgical follow-up, it is typically a straightforward outpatient procedure.